Endocrinology

>

Latest News

FDA approves dapagliflozin to improve glycemic control in pediatric T2D patients | Image Credit: © Calin - © Calin - stock.adobe.com.
FDA approves dapagliflozin to improve glycemic control in pediatric T2D patients

June 12th 2024

The decision is based on statistical significance achieved in the T2NOW trial, which demonstrated reduction of A1C.

Adverse social determinants of health associated with prediabetes | Image Credit: © greenapple78 - © greenapple78 - stock.adobe.com.
Adverse social determinants of health associated with prediabetes

June 11th 2024

Adolescent GLP-1 prescriptions increased 6-fold from 2020 to 2023
Adolescent GLP-1 prescriptions increased 6-fold from 2020 to 2023

May 24th 2024

T2D risk increased with increased HbA1c levels among adolescents with overweight, obesity | | Image Credit: © Andrey - © Andrey - stock.adobe.com.
T2D risk increased with increased HbA1c levels among adolescents with overweight, obesity

May 15th 2024

First radioactive drug approved for patients 12 years and up with SSTR-positive GEP-NETs | Image Credit: © Calin - © Calin - stock.adobe.com.
First radioactive drug approved for patients 12 years and up with SSTR-positive GEP-NETs

April 23rd 2024

More News

© 2024 MJH Life Sciences

All rights reserved.